The measles vaccine arrived in two versions, starting in 1963
The first measles vaccine became available in the United States in 1963. It was an inactivated (killed) virus vaccine, developed by researcher John Enders and his team. A live attenuated (weakened) version followed in 1967 and became the standard because it provided stronger, longer-lasting immunity with a single dose.
Before the vaccine existed, measles was a common childhood disease that killed hundreds of Americans each year and left others with permanent brain damage, deafness, or blindness. The 1963 introduction marked the beginning of the end for measles as a major public health threat in the United States, though it took years of widespread vaccination to reach that point.
Key Takeaways
- The inactivated measles vaccine was licensed in 1963; the live attenuated version replaced it in 1967 and remains the basis for today's MMR shot.
- Measles deaths in the U.S. dropped from hundreds per year in the early 1960s to near zero by the 1980s as vaccination rates climbed.
- The vaccine is given as part of the MMR (measles, mumps, rubella) combination shot, typically at 12 to 15 months of age and again at 4 to 6 years old.
- Measles outbreaks still occur in areas where vaccination rates fall below 90 to 95 percent, because the virus spreads easily to unvaccinated people.
How the 1963 vaccine worked and why it changed
The 1963 inactivated vaccine used killed measles virus to train the immune system to recognize the disease. It worked, but immunity faded over time and required booster shots. The live attenuated vaccine introduced in 1967 used a weakened form of the virus that could still infect cells but could not cause the full disease. This approach created stronger, more durable immunity—often lifelong protection from a single dose.
The live vaccine became standard because it was more effective and easier to deliver. A person vaccinated with the live version at age one typically remained protected into adulthood without needing additional shots. This made it practical for large-scale public health campaigns, which is why nearly every country adopted it as the measles vaccine of choice.
Measles deaths and cases before and after vaccination
In the years before the vaccine, measles infected nearly every American child. The disease killed between 400 and 500 people per year in the United States during the late 1950s and early 1960s. Thousands more were hospitalized with pneumonia, encephalitis (brain inflammation), or other complications. Measles was also a leading cause of childhood blindness and deafness.
After the vaccine rolled out and vaccination rates climbed through the 1970s and 1980s, measles deaths dropped to single digits per year. By 2000, measles was declared eliminated from the United States—meaning the virus was no longer spreading continuously in the population. The disease did not disappear entirely because travelers could still bring it in, but the vaccine had removed it as a routine threat to American children.
How the measles vaccine is given today
The measles vaccine is not given alone. It is part of the MMR shot, which protects against measles, mumps, and rubella in one injection. The standard schedule calls for the first dose at 12 to 15 months of age and a second dose at 4 to 6 years old. Two doses provide protection to more than 99 percent of people who receive them.
The MMR vaccine is a live attenuated vaccine, meaning it contains weakened virus. It cannot cause measles, mumps, or rubella in healthy people, though some recipients experience mild side effects like a low fever or rash one to two weeks after vaccination. Serious side effects are extremely rare.
Why measles still spreads in unvaccinated communities
Measles is one of the most contagious diseases known. A single infected person spreads it to 12 to 18 unvaccinated people on average. This means that in a community where fewer than 90 to 95 percent of people are vaccinated, the virus can find enough unvaccinated hosts to keep spreading. When vaccination rates fall below that threshold, outbreaks occur.
The United States has experienced measles outbreaks in recent years, particularly in areas where vaccination rates are lower. These outbreaks have sickened hundreds of people and killed at least one person. The outbreaks demonstrate that measles did not disappear—it is still circulating globally and can return quickly wherever vaccination coverage drops.
Measles vaccine development in other countries
The measles vaccine was developed and licensed in the United States first, but other countries introduced it shortly after. The Soviet Union licensed its own live attenuated vaccine in 1967, the same year the U.S. switched to the live version. Most developed nations had measles vaccination programs in place by the 1970s.
Global measles vaccination campaigns began in the 1980s and 1990s, led by organizations including the World Health Organization and UNICEF. These campaigns have prevented millions of deaths worldwide. However, measles remains endemic in parts of Africa, Asia, and the Middle East where vaccination coverage is lower, and outbreaks in those regions can seed cases in other countries through travel.
What changed about measles after the vaccine arrived
Before 1963, measles was a disease nearly every child caught. Parents expected it, schools closed during outbreaks, and hospitals filled with measles patients each winter. After vaccination became widespread, measles became rare enough that many people born after 1980 have never seen a case.
This shift created a new challenge: as measles became less common, fewer doctors had experience recognizing it, and some parents questioned whether vaccination was necessary. Measles outbreaks in the 2010s and 2020s occurred partly because vaccination rates had fallen in some communities—a reminder that the disease remains a threat wherever immunity is not maintained.
Frequently Asked Questions
Is the measles vaccine the same now as it was in 1967?
The basic vaccine is the same—a live attenuated virus—but manufacturing has improved. Modern vaccines are more purified and more carefully tested. The MMR combination was introduced in 1971, combining measles, mumps, and rubella into one shot. The formulation has been refined since then, but the measles component remains a live attenuated virus.
Can someone vaccinated in the 1960s or 1970s still be protected?
Most people who received the live attenuated vaccine as children remain protected into adulthood. Studies show that immunity from the live vaccine is durable, often lasting a lifetime. However, people vaccinated with the inactivated vaccine in 1963 to 1967 may have waning immunity and could benefit from revaccination with the live vaccine.
Why didn't measles disappear completely like smallpox?
Smallpox was eradicated because the vaccine prevented transmission entirely—vaccinated people could not catch or spread it. Measles vaccine prevents disease but does not always prevent infection, so the virus can still circulate in vaccinated populations at very low levels. Measles also has animal reservoirs in some parts of the world, making global eradication harder.
What happens if someone born before 1957 was never vaccinated?
People born before 1957 are generally considered immune to measles because nearly everyone caught the disease as a child before the vaccine existed. However, some people born in that era were vaccinated, and a small number never caught measles and were never vaccinated. If unsure, a blood test can check for immunity.